Coloplast A/S

OTC: CLPBY · Real-Time Price · USD
9.60
0.07 (0.72%)
At close: Jun 06, 2025, 3:58 PM

Coloplast A/S Income Statement

Financials in DKK. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Revenue
6.93B 7.03B 6.95B 6.88B 6.59B 6.61B 6.23B 6.11B 6.06B 6.11B 6.06B 5.85B 5.5B 5.17B 5.1B 4.83B 4.75B 4.74B
Cost of Revenue
2.2B 2.28B 2.31B 2.24B 2.11B 2.1B 2.09B 2.08B 2.03B 1.96B 1.89B 1.8B 1.72B 1.64B 1.58B 1.5B 1.5B 1.53B
Gross Profit
4.73B 4.75B 4.64B 4.65B 4.48B 4.5B 4.13B 4.02B 4.03B 4.15B 4.17B 4.05B 3.78B 3.53B 3.52B 3.33B 3.25B 3.21B
Operating Income
1.89B 1.91B 1.91B 1.86B 1.79B 1.82B 1.65B 1.71B 1.65B 1.76B 1.78B 1.74B 1.3B 1.61B 1.85B 1.59B 1.38B 1.54B
Interest Income
n/a 52M 28M 34M 36M 22M 29M 37M 42M 1M 5M 79M 50M 2M 3M 44M 98M 2M
Pretax Income
1.49B 1.77B 1.6B 1.63B 1.61B 1.55B 1.53B 1.61B 1.46B 1.43B 1.61B 1.67B 1.29B 1.56B 1.64B 1.62B 1.48B 1.5B
Net Income
912M 1.04B 1.31B 1.27B 1.25B 1.21B 1.23B 1.27B 1.16B 1.13B 1.23B 1.29B 980M 1.21B 1.3B 1.25B 1.13B 1.14B
Selling & General & Admin
2.63B 2.62B 2.58B 2.55B 2.48B 2.46B 2.18B 2.13B 2.16B 2.16B 2.15B 2.08B 1.88B 1.69B 1.67B 1.58B 1.5B 1.5B
Research & Development
239M 219M 219M 240M 221M 233M 231M 216M 209M 216M 217M 222M 222M 205M 207M 185M 177M 186M
Other Expenses
-28M -5M -63M 23M -11M -5M -20M -6M -12M -6M -9M -18M -11M -11M -3M -27M -3M -11M
Operating Expenses
2.84B 2.84B 2.73B 2.79B 2.69B 2.68B 2.42B 2.34B 2.36B 2.37B 2.36B 2.29B 2.1B 1.88B 1.87B 1.74B 1.67B 1.67B
Interest Expense
316M 204M 219M 237M 201M 174M 187M 141M 232M 122M 92M 149M 68M 6M 6M 17M n/a 7M
Selling & Marketing Expenses
2.33B 2.33B 2.29B 2.25B 2.15B 2.13B 1.91B 1.87B 1.88B 1.86B 1.87B 1.81B 1.62B 1.49B 1.45B 1.4B 1.32B 1.31B
Cost & Expenses
5.04B 5.11B 5.05B 5.03B 4.81B 4.78B 4.51B 4.42B 4.39B 4.33B 4.25B 4.09B 3.82B 3.52B 3.45B 3.24B 3.18B 3.2B
Income Tax Expense
579M 725M 289M 357M 355M 342M 298M 338M 306M 300M 382M 382M 307M 350M 339M 365M 345M 359M
Shares Outstanding (Basic)
2.25B 2.25B 2.25B 2.25B 2.25B 2.19B 2.18B 2.12B 2.12B 2.12B 2.12B 2.12B 2.13B 2.13B 2.13B 2.13B 2.13B 2.13B
Shares Outstanding (Diluted)
2.25B 2.25B 2.25B 2.25B 2.25B 2.19B 2.25B 2.13B 2.12B 2.12B 2.13B 2.13B 2.13B 2.13B 2.13B 2.13B 2.13B 2.13B
EPS (Basic)
0.41 0.46 0.58 0.57 0.56 0.55 0.56 0.60 0.54 0.53 0.58 0.61 0.46 0.57 0.61 0.59 0.53 0.53
EPS (Diluted)
0.41 0.46 0.58 0.57 0.56 0.55 0.55 0.60 0.54 0.53 0.58 0.61 0.46 0.57 0.61 0.59 0.53 0.53
EBITDA
2.15B 2.3B 2.13B 2.2B 2.13B 2.13B 2.01B 1.95B 1.94B 2.04B 2.01B 2.02B 1.92B 1.82B 1.85B 1.8B 1.77B 1.74B
EBIT
1.81B 1.97B 1.8B 1.87B 1.81B 1.73B 1.71B 1.75B 1.69B 1.55B 1.7B 1.82B 1.35B 1.56B 1.65B 1.64B 1.58B 1.5B
Depreciation & Amortization
344M 328M 335M 328M 319M 308M 277M 263M 268M 261M 259M 260M 236M 175M 191M 209M 190M 202M